Evidence map›Paper›PMID 20053998›Full record

ArticleThe Journal of biological chemistry2010

p38 regulates pigmentation via proteasomal degradation of tyrosinase.

Barbara Bellei, Vittoria Maresca, Enrica Flori, Angela Pitisci, Lionel Larue, Mauro Picardo

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 118 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Anti-melanogenic effects of Medicago sativa seed extracts on melanocytes.International journal of cosmetic science · 2025
    Article
  7. Article
  8. Article
  9. Anti-Melanogenic Effects ofPlants (Basel, Switzerland) · 2024
    Article
  10. Two High-QualityInternational journal of molecular sciences · 2023
    Article
  11. Review
  12. Article
  13. SNA077, an Extract of MarineInternational journal of molecular sciences · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Barbara BelleiLaboratory of Cutaneous Physiopathology, San Gallicano Dermatologic Institute, IRCCS, 00144 Rome, Italy.
Vittoria Maresca
Enrica Flori
Angela Pitisci
Lionel Larue
Mauro Picardo
San Gallicano Hospital · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITInstitut Curie · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The synthesis of melanin pigments, or melanogenesis, is regulated by the balance of a variety of signal transduction pathways. Among these pathways, p38 MAPK signaling was found to be involved in stress-induced melanogenesis and to be activated by alpha-melanocyte-stimulating hormone (alpha-MSH) and ultraviolet irradiation. Previous studies have shown that alpha-MSH-stimulated melanogenesis can be inhibited by blocking p38 MAPK activity with SB203580, a pyridinyl imidazole compound. Consistent with this, we observed that pyridinyl imidazoles (SB203580 and SB202190) inhibited both basal and alpha-MSH-induced melanogenesis in B16 melanoma cells. However, SB202474, which has no ability to inhibit p38 MAPK activity and is usually used as a negative control compound in p38 MAPK studies, also suppressed melanin synthesis induction. Furthermore, the independence of the p38 kinase pathway from the repression of melanogenesis by pyridinyl imidazole compounds was also confirmed by small interfering RNA experiments. Interfering with p38 MAPK expression surprisingly stimulated melanogenesis and tyrosinase family protein expression. Although the molecular mechanism(s) by which p38 promotes the degradation of melanogenic enzymes remain to be determined, the involvement of the ubiquitin-proteasome pathway was demonstrated by co-treatment with the proteasome-specific inhibitor MG132 and the relative decrease in the ubiquitination of tyrosinase in cells transfected with p38-specific small interfering RNA.

Indexed as

alpha-MSHAnimalsEnzyme InhibitorsEnzyme StabilityGene Expression RegulationHumansImidazolesMAP Kinase Signaling SystemMelaninsMelanoma, ExperimentalMiceMicrophthalmia-Associated Transcription FactorMonophenol Monooxygenasep38 Mitogen-Activated Protein KinasesPigmentationProteasome Endopeptidase Complex4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazolealpha-MSHEnzyme InhibitorsImidazolesMelaninsMicrophthalmia-Associated Transcription FactorMonophenol Monooxygenasep38 Mitogen-Activated Protein KinasesProteasome Endopeptidase ComplexPyridinesRNA, Small InterferingSB 203580Ubiquitinated Proteins

Identifiers

PMID20053998
PMCPMC2844177
OpenAlexW1968873996

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.